Understanding the research behind Lion's Mane: Erinacines

Understanding the research behind Lion's Mane: Erinacines

What is Erinacine?

Erinacines are a newly discovered group of compounds found only in species of Hericium mushrooms. These compounds are being studied in depth due to their remarkable potential for our bodies to use in for the nervous system. In the past few years, scientists have been studying the molecular structure and therapeutic properties of these compounds to develop treatments for Alzheimer’s disease and other neurological conditions.

How Do Erinacines Work?

To understand how erinacines work, it is important to first understand their molecular structure. Erinacines are cyathin diterpenoids, which means they contain two chemical rings linked together by an oxygen atom. These two rings form a stable bond that gives the compound its unique chemical properties. To date, 15 erinacines (erinacines A-K and P-S) have been identified.

One of the most promising properties of erinacines is their ability to stimulate the synthesis of nerve growth factor (NGF). NGF is a protein found in the brain that helps neurons grow and repair themselves over time. By increasing NGF levels in the brain, erinacines can potentially promote neuronal regeneration and may potentially lessen the negative effects of an aging brain with long term use. Several erinacines have been shown to increase NGF levels both in vitro (laboratory experiments) and in vivo (tests on living animals).

Other Applications of Erinacines

In addition to increasing NGF levels, erinacines have also been found to decrease amyloid-ß plaque deposition – one of the primary causes of Alzheimer’s disease – as well as increase levels of insulin-degrading enzymes (erinacine A and S). These positive effects on amyloid-ß plaque deposition could potentially reduce symptoms associated with Alzheimer's disease such as memory loss and confusion.

Erinacine research has also provided insight into ways that these compounds may be used to protect neurons against injury or death due to stroke or other traumatic events. When administered before a stroke occurs, erinacines may help reduce damage caused by cell death while also protecting healthy cells from dying off due to a lack of oxygen supply or increased oxidative stress. This neuroprotective effect has been demonstrated in laboratory tests using animal models.

The potential applications for erinacine research don’t end there either - scientists are continuing to explore new ways that these compounds can be used for therapeutic purposes. For example, research into erinacine B has revealed its ability to induce long-term potentiation in neurons – a critical process for learning and memory formation – suggesting that it might one day be used as adjuvant therapy for cognitive impairments associated with aging or neurodegenerative diseases such as Alzheimer’s disease or Parkinson’s disease .


Overall, the science behind erinacines is truly remarkable - they potentially offer new hope for treating neurological disorders like Alzheimer's disease and other age-related cognitive impairments through their stimulating effect on NGF production as well as their neuroprotective effects against cell death due to stroke or oxidative stress damage. As more research is done into this compound class, we may soon begin seeing more effective therapies available for treating neurological conditions ranging from mild cognitive impairments to severe forms of dementia like Alzheimer's disease.

DISCLAIMER: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.